Objectives: This study aims to provide insight into cellular kinetics using molecular imaging
after different transplantation methods of bone marrow–derived mononuclear cells (MNCs) …

Background—Cell therapy with bone marrow–derived stem/progenitor cells is a novel option
for improving neovascularization and cardiac function in ischemic heart disease. Circulating …

Objective: Bone marrow cell therapy promotes angiogenesis, but the cellular fate of bone
marrow cells (BMCs) in the absence of immunosuppressant interventions is unclear. We …

Purpose To develop a magnetic resonance imaging (MRI)‐based method to monitor in vivo
trafficking of bone marrow (BM) cells to atherosclerotic lesions. Materials and Methods BM …

Therapeutic augmentation of collateral artery growth (arteriogenesis) is of tremendous
clinical interest. Since monocytes home to areas of arteriogenesis and create a local …

Autolougous transplantation of granulocyte colony-stimulating factor (G-CSF)-mobilized
human peripheral blood mononuclear cells (PBMNCs) improves limb ischemia in patients …

A characteristic feature of atherosclerotic cardiovascular disease is the diffuse involvement
of arteries across the entire human body and the presence of multiple, simultaneous lesions …

Animal experiment models have demonstrated that implantation of autologous bone marrow
mononuclear cells (BM-MNC) is an effective technique for inducing therapeutic …

Background The custom microenvironment'vascular niche'is a potential therapeutic target for
several pathophysiological conditions. Osteoblasts regulate the hematopoietic stem cell …

Bone marrow mononuclear cell (BMMC) therapy shows promise as a treatment for ischemic
heart disease. However, the ability to monitor long-term cell fate remains limited. We …